Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Jun 8, 2026 3:59:59 PM EDT

223.01USD-1.857%(-4.22)4,873,156

213.94Bid 233.87Ask 19.93Spread

Pre-market

Jun 8, 2026 9:15:30 AM EDT

225.50USD-0.761%(-1.73)3,635

After-hours

Jun 8, 2026 4:10:30 PM EDT

223.07USD+0.027%(+0.06)1,040,381

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

394.03B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Jul 30, 2026 (52d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

5,698,810

Avg. Vol. 30 Day

6,090,144

Employees

30,000

Market Cap

394,030,134,939

Shares Out.

1,766,792,821

On/Off Exchange

51%/49%

6 Month Beta

0.17

1 Year Beta

0.14

2 Year Beta

0.31

3 Year Beta

0.32

52 Week Low

181.73

52 Week High

244.81

SMA50

209.61

SMA200

219.95

1 Week

+4.74%

1 Month

+10.65%

3 Month

-1.95%

6 Month

-0.05%

1 Year

+17.90%

2 Year

+31.64%

5 Year

+98.52%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $223.01, and today's volume is 4,873,156. ABBV is down -1.857% today. The 30 day average volume is 6,090,144. ABBV market cap is 394.03B with 1,766,792,821 shares outstanding.

document.getElementById("JzWJcz").onerror = function(){this.style.display='none';}; .dark-mode .Kq43qr{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Kq43qr{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE